RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Accuro® XV Diagnostic ...
RIVANNA receives US FDA 510(k) clearance for its Accuro XV musculoskeletal ultrasound imaging system
RIVANNA receives US FDA 510(k) clearance for its Accuro XV musculoskeletal ultrasound imaging system: Charlottesville, Virginia Saturday, May 9, 2026, 13:00 Hrs [IST] RIVANNA, a d ...
Segment-any-crack inspects roads, buildings and bridges using a fraction of the computational power of previous methods ...
Google quietly updated Search Terms reporting for AI Mode, AI Overviews, Lens, and autocomplete. Here’s why advertisers may ...
The global Medtech Market size is set to witness a growth rate of 7% in the next 5 years. Rising volumes of surgical and ...
Campaign Middle East on MSN
Marketing beyond generational labels
For years, marketers have leaned into generational labels as if they were strategic shortcuts: Baby Boomers, millennials, Gen ...
Global Veterinary Imaging Market OverviewThe global veterinary imaging market is experiencing steady expansion and is ...
Children and adolescents with chronic conditions, such as inflammatory bowel disease, juvenile idiopathic arthritis, or those undergoing long-term ...
Investigators utilized Automated Quantitative Ulcer Analysis to compare microbial keratitis demographics, clinical ...
The TreeScanPL10K dataset provides over 10,000 annotated TLS point clouds, advancing precision forestry and ecological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results